Nanalysis Scientific (TSE:NSCI) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study demonstrating the effectiveness of benchtop NMR technology for quality control in pharmaceuticals. The study highlights the advantages of this portable NMR solution, including faster measurements and reduced solvent usage, making it an accessible and scalable option for the industry. This advancement positions Nanalysis Scientific to potentially drive growth in pharmaceutical quality assurance globally.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Zeta Global Holdings Corp. (NYSE:ZETA)
- Class Action Lawsuit Against Toronto-Dominion Bank (NYSE:TD)
- 3 Penny Stocks to Watch Now, 12/12/24
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
